Latest Malin News & Updates

See the latest news and media coverage for Malin. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Malin

Publicly listed life sciences investment company

malinplc.com
Headquarters
Dublin 2, Ireland
Founded year
2015
Company type
Public company
Number of employees
10–50

Last updated

Latest news about Malin

In short: Malin returned €150 million to shareholders and saw its investment portfolio shrink significantly, leading to the departure of its CEO.

Company announcements

  • Malin

    Sanofi announces positive phase 3 results for amlitelimab

    Amlitelimab met key endpoints in SHORE and COAST 2 studies for atopic dermatitis treatment. Sanofi plans global regulatory submissions in H2 2026.

  • Malin

    Mycovia announces publication of 2-year VIVJOA efficacy results

    The VIOLET Phase 3 extension study showed 98% of women remained infection-free versus 82% on placebo for nearly two years. VIVJOA is FDA-approved for RVVC in non-reproductive potential women.

  • Malin

    Malin launches tender offer for €150 million

    The offer at €10.30 per share closes 20 March 2025, pending shareholder approval at EGM on 13 March 2025.

  • Malin

    Malin reports positive interim phase 1 results for Poseida therapies

    The data highlight P-BCMA-ALLO1 and P-CD19CD20-ALLO1 therapies' efficacy and safety in multiple myeloma and B-cell malignancies with ongoing clinical trials.

Unlock all announcements with a

Media coverage

Unlock all articles with a

Never miss news about Malin

Track Malin and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Malin competitors & trending companies

Browse news for competitors to Malin and other trending companies.